Diagnosis and management of multiple myeloma and related disorders.
Kyle
R A
RA
D000477:Alkylating Agents / Q000008:administration & dosage; D000686:Amyloidosis / Q000175:diagnosis / Q000628:therapy; D000740:Anemia / Q000209:etiology; D000753:Anemia, Refractory / Q000139:chemically induced; D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D001424:Bacterial Infections / Q000209:etiology; D001803:Blood Transfusion; D001856:Bone Marrow Examination; D016026:Bone Marrow Transplantation; D001859:Bone Neoplasms / Q000175:diagnosis / Q000628:therapy; D001842:Bone and Bones / Q000000981:diagnostic imaging; D002118:Calcium / Q000097:blood; D003131:Combined Modality Therapy; D003937:Diagnosis, Differential; D006362:Heavy Chain Disease / Q000175:diagnosis; D006801:Humans; D007072:Immunoglobulin D / Q000032:analysis; D007167:Immunotherapy; D007372:Interferons / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000209:etiology; D007938:Leukemia / Q000175:diagnosis; D008558:Melphalan / Q000008:administration & dosage; D051379:Mice; D008998:Monoclonal Gammopathy of Undetermined Significance / Q000175:diagnosis / Q000628:therapy; D009101:Multiple Myeloma / Q000097:blood / Q000145:classification / Q000150:complications / Q000175:diagnosis* / Q000628:therapy; D009194:Myeloma Proteins / Q000032:analysis; D010014:Osteolysis; D010026:Osteosclerosis / Q000209:etiology; D010265:Paraproteinemias / Q000175:diagnosis / Q000628:therapy; D010950:Plasma Cells / Q000473:pathology; D010954:Plasmacytoma / Q000175:diagnosis / Q000628:therapy; D011241:Prednisone / Q000008:administration & dosage; D011877:Radionuclide Imaging; D008258:Waldenstrom Macroglobulinemia / Q000175:diagnosis / Q000628:therapy
D000477:Alkylating Agents; D000911:Antibodies, Monoclonal; D007072:Immunoglobulin D; D009194:Myeloma Proteins; D007372:Interferons; D008558:Melphalan; D002118:Calcium; D011241:Prednisone